Malware Monitor by Morphisec | March 5th
Welcome back to the Morphisec Malware Monitor.?We guarantee you’ll find this edition insightful.?
Industry Headline Scan?
Morphisec’s Ransomware-Free Guarantee: Setting a New Standard for Anti-Ransomware Protection?– Morphisec?
Morphisec is setting a new benchmark with its Anti-Ransomware Assurance Suite and the recently launched Ransomware-Free Guarantee, cementing its position as the #1 trusted, best-of-breed Anti-Ransomware Protection solution on the market.?
Under this program, if a ransomware breach occurs despite the use of Morphisec’s solutions, the company offers:??
Cisco, Hitachi, Microsoft, and Progress Flaws Actively Exploited—CISA Sounds Alarm?– The Hacker News?
On Monday, CISA added five security flaws impacting software from Cisco, Hitachi Vantara, Microsoft Windows, and Progress WhatsUp Gold to its Known Exploited Vulnerabilities (KEV) catalog?
The list of vulnerabilities is as follows -?
Congratulations to Arnold and Michael!?
Two members of the Morphisec research team have been recognized as Most Valuable?
Security Researchers by Microsoft: CTO Michael Gorelik and Malware Researcher Arnold Osipov. These two have been delivering constant insights into Microsoft Office Remote Code Execution Vulnerabilities over the last year, and their award is well-deserved.?
Next up for the dynamic duo: Microsoft Zero-Day Quest!?
Morphisec Expert Insights?
Our resident Gartner Veteran Brad LaPorte has been busy, so we have not one, but two webinars for you!?
First, Brad recently sat down with Enterprise Management 360 for an expert panel focused on the future of cybersecurity. This can’t-miss discussion features unique insights from some of the people helping shape the future of the industry. Listen here!?
Next: Brad is leading a session with Morphisec focused on actionable predictions for 2025 and beyond! Make sure to clear your calendar at 11 AM ET on March 19th, as we cover 13 predictions for 2025 ranging from sure-things to bold but not impossible. RSVP now!?
Closing Notes?
?